ParB spreading on DNA requires cytidine triphosphate in vitro

  1. Adam SB Jalal
  2. Ngat T Tran
  3. Tung BK Le  Is a corresponding author
  1. Department of Molecular Microbiology, John Innes Centre, United Kingdom
7 figures, 1 table and 2 additional files

Figures

Figure 1 with 3 supplements
CTP reduces the nucleation of Caulobacter ParB at parS.

(A) The domain architecture of ParB (dark green) and TetR (grey), and their respective DNA-binding sites parS and tetO. Convergent arrows below DNA-binding sites indicate that parS and tetO are palindromic. (B) Bio-layer interferometric (BLI) analysis of the interaction between a premix of 1 μM ParB-His6 dimer ± 1 mM NTP and a 20 bp DNA duplex containing parS. Biotinylated DNA fragments were immobilized onto the surface of a Streptavidin (SA)-coated probe (See Materials and methods). The BLI probe was dipped into a buffer only solution (0–30 s), then to a premix of protein ± NTP (30–150 s: association phase), and finally returned to a buffer only solution (150–270 s: dissociation phase). Sensorgrams were recorded over time. BLI analysis of the interaction between 1 μM TetR-His6 and a 20 bp parS probe was also recorded (a negative control). (C) BLI analysis of the interaction between a premix of 1 μM TetR-His6 ± 1 mM NTP and a 28 bp DNA duplex containing tetO. BLI analysis of the interaction between 1 mM CTP and a 28 bp tetO probe was also recorded (a negative control). (D) BLI analysis of the interaction between 1 μM Caulobacter ParB-His6 (without CTP) and a 20 bp parS DNA. For the dissociation phase, the probe was returned to a buffer only or buffer supplemented with 1 mM CTP. All buffers used for experiments in this figure contained Mg2+. Each BLI experiment was triplicated and a representative sensorgram was presented.

Figure 1—figure supplement 1
ParB and TetR bind specifically to their cognate-binding sites parS and tetO, respectively.

(A) BLI analysis of the interaction between purified Caulobacter ParB-His(0.125 to 2 µM) and a 20 bp parS DNA probe or a 28 bp tetO DNA probe. (B) BLI analysis of the interaction between purified TetR-His(0.125 to 2 µM) and a 20 bp parS DNA probe or a 28 bp tetO DNA probe.

Figure 1—figure supplement 2
BLI analysis of the interaction between purified Caulobacter ParB and NTP in buffers lacking Mg2+.

Caulobacter ParB-His6 (1 µM dimer)±1 mM NTP, and a 20 bp DNA duplex containing parS were used. Mg2+ was omitted from all buffers in this experiment. A schematic of the DNA substrate is shown above the sensorgram.

Figure 1—figure supplement 3
BLI analysis of the interaction between purified Caulobacter ParB and cytidine mono-, di-, or triphosphate.

(A) BLI analysis of the interaction between purified Caulobacter ParB and an increasing concentration of CTP-Mg2+. ParB-His6 (1 µM dimer) + 0–10 mM CTP, and a 20 bp DNA duplex containing parS were used for this experiment. (B) BLI analysis of the interaction between a premix of 1 μM Caulobacter ParB-His6 ± 1 mM cytidine mono-, di-, or triphosphate, and a 20 bp parS DNA. A schematic of the DNA substrate is shown above the sensorgram. Mg2+ was included in all buffers for experiments in this figure.

Figure 2 with 3 supplements
CTP facilitates ParB association with a closed DNA substrate beyond nucleation.

(A) BLI analysis of the interaction between a premix of 1 μM Caulobacter ParB-His6 ± 1 mM NTP and a 169 bp dual biotin-labeled DNA containing a parS or a scrambled parS site. Interactions between a dual biotinylated DNA and streptavidin (SA)-coated probe created a DNA substrate where both ends were blocked (a closed DNA substrate) (see the schematic of the BLI probes above the sensorgram). (B) Interactions between a nucleation-competent but spreading-defective ParB (R104) variant with a 169 bp parS DNA fragment in the presence or absence of CTP were also recorded. Each BLI experiment was triplicated and a representative sensorgram was presented. (C) A schematic of the pull-down assay and immunoblot analysis of pulled-down Caulobacter ParB-His6. The length of bound DNA is ~2.8 kb. Beads were incubated with ParB protein for five minutes before being pulled down magnetically. All buffers used for experiments in this figure contained Mg2+.

Figure 2—figure supplement 1
Dual biotin-labeled DNA fragments form a closed substrate on the surface of the BLI probe.

(A) A schematic of a double digestion assay using Exonuclease T7 + Exonuclease VII and PCR. PCR was performed using M13F, M13R oligos, and DNA attached to the BLI surface as a template. (B) The BLI probe was severed from the plastic adaptor and immerged into a PCR master mix. (C) Dual biotin-labeled DNA fragments on the BLI surface were resistant to Exo T7 + Exo VII digestion while single biotin-labeled DNA fragments on the BLI surface were not.

Figure 2—figure supplement 2
CTP-Mg2+ enhances ParB accumulation on a closed DNA substrate.

(A) BLI analysis of the interaction between an increasing concentration of Caulobacter ParB-His6 (0.125 to 1.0 µM) + 1 mM CTP and a 169 bp dual biotin-labeled parS DNA. A schematic of the DNA substrate is shown above the sensorgram. (B) BLI analysis of the interaction between 1 μM Caulobacter ParB-His6 (with 1 mM CTP) and a 169 bp dual biotin-labeled parS DNA. For the dissociation phase, the probe was returned to a buffer only or buffer supplemented with 1 mM CTP solution. All buffers used for experiments in panel A-B contained Mg2+. (C) BLI analysis of the interaction between a premix of 1 μM Caulobacter ParB-His6 ±1 mM CTP and a 169 bp dual biotin-labeled DNA containing a parS site in buffer with or without MgCl2.

Figure 2—figure supplement 3
CTP facilitates the association of eight ParB orthologs with DNA.

BLI analysis of the interaction between a premix of 1 μM His6-MBP-tagged ParB proteins from a set of diverse bacterial species ± NTPs and a 169 bp dual biotin-labeled parS DNA. NTPs at 1 mM (final concentration) was used, except for BLI experiments with Zymomonas mobilis and Xanthomonas campestris ParBs where 0.01 mM CTP was used instead. Mg2+ was included in all buffers for this experiment. A schematic of the DNA substrate is shown above the sensorgrams.

Figure 3 with 2 supplements
A closed DNA substrate is required for an increased association of ParB with DNA.

(A) BLI analysis of the interaction between a premix of 1 μM Caulobacter ParB-His6 ± 1 mM CTP and a 169 bp dual biotin-labeled parS DNA. (B) Same as panel A but immobilized DNA fragments have been restricted with BamHI before BLI analysis. (C) Same as panel A but immobilized DNA fragments have been restricted with EcoRI before BLI analysis. Schematic of DNA fragments with the relative positions of parS and restriction enzyme recognition sites are shown above the sensorgram. Each BLI experiment was triplicated and a representative sensorgram was presented. (D) A schematic of the pull-down assay and immunoblot analysis of pulled-down Caulobacter ParB-His6. For lanes 3 and 4, DNA-bound beads were incubated with HindIII to linearize bound DNA. Samples in lanes 1–4 were loaded on the same gel, the immunoblot was spliced together for presentation purposes. All buffers used for experiments in this figure contained Mg2+.

Figure 3—figure supplement 1
Restriction enzymes linearize dual biotin-labeled DNA fragments on the surface of the BLI probe.

(A) (Left panel) A schematic of a digestion assay using BamHI/EcoRI and PCR. PCR was performed using M13F, M13R oligos, and DNA attached to the BLI surface as a template. (Right panel) The BLI probe was severed from the plastic adaptor and immerged into a PCR master mix. (B) Detection of intact 169 bp DNA fragments that were bound on the surface of the BLI probe before and after treatment with restriction enzymes.

Figure 3—figure supplement 2
Linearization of a closed DNA substrate by BamHI liberates pre-bound ParB from DNA.

BamHI was added after 1 μM Caulobacter ParB-His6 + 1 mM CTP and a 169 bp dual biotin-labeled parS DNA were preincubated together for 120 s. As a negative control, heat-inactivated BamHI was added instead. Mg2+ was included in all buffers for this experiment. A schematic of the DNA substrate is shown above the sensorgram.

Figure 4 with 1 supplement
TetR-tetO binding restores ParB association with an open DNA substrate.

(A) BLI analysis of the interaction between a premix of 1 μM Caulobacter ParB-His6 ± 1 mM CTP ± 1 μM TetR-His6 and a 170 bp dual biotin-labeled DNA containing a parS site. (B) Same as panel A but immobilized DNA fragments have been restricted with BamHI before BLI analysis. (C) Same as panel A but immobilized DNA fragments have been restricted with EcoRI before BLI analysis. Schematic of DNA fragments together with the relative positions of parS, tetO, and restriction enzyme recognition sites are shown above the sensorgram. Each BLI experiment was triplicated and a representative sensorgram was presented. All buffers used for experiments in this figure contained Mg2+.

Figure 4—figure supplement 1
Anhydrotetracycline removes DNA-bound TetR roadblock and allows ParB to accumulate further on DNA.

Anhydrotetracycline (3 μM) or ethanol (0.01%) was added after 1 μM Caulobacter ParB-His6 + 1 mM CTP ± 1 μM TetR and a 170 bp dual biotin-labeled parS DNA were preincubated together for 120 s. Mg2+ was included in all buffers for this experiment. A schematic of the DNA substrate is shown above the sensorgram.

parS DNA increases the CTP binding and hydrolysis rate by Caulobacter ParB.

(A–B) CTP binding as monitored by DRaCALA assay using radiolabeled CTP α-P32. The bulls-eye staining indicates CTP binding due to a more rapid immobilization of protein-ligand complexes compared to free ligands alone. The starting concentration of proteins used in panel A was 25 μM. The same concentration of radioactive CTP, unlabeled CTP, and DNA was used in experiments shown in panels A and B. (C) A continuous monitoring of inorganic phosphate (Pi) released by recording absorbance at 360 nm overtime at 25°C. The rates of CTP hydrolysis were inferred from a Pi standard. The NTP hydrolysis of Caulobacter ParB was also monitored in the presence of ATP, GTP, or UTP, with a 22 bp parS DNA duplex or a non-cognate 22 bp NBS DNA duplex (a DNA-binding site of Noc protein Wu and Errington, 2004). The nucleation-competent but spreading-defective ParB (R104A) mutant did not hydrolyze CTP in the presence of parS DNA. All buffers used for experiments in this figure contained Mg2+.

Figure 6 with 2 supplements
ParB accumulation on DNA is unstable in the presence of a non-hydrolyzable analog CTPγS.

(A) (Left panel) BLI analysis of the interaction between a premix of 1 μM Caulobacter ParB-His6 ± 1 mM CTP or CTPγS and a 169 bp dual biotin-labeled parS DNA. Purified ParB was preincubated with CTP or CTPγS for 1, 5, 15, 30, or 60 min before BLI analysis. (Right panel) Quantification of ParB-DNA interaction at the end of each association phase (150th sec). Error bars represent SD from three replicates. (B) (Left panel) Time course of Caulobacter ParB (Q35C C297S) cross-linking with CTP or CTPγS in the absence of parS DNA. Purified ParB-His6 (Q35C C297S) (10 µM) were preincubated with 1 mM CTP or CTPγS for 1, 5, 10, 15, or 30 min before BMOE was added. X indicates a cross-linked form of ParB. (Right panel) Quantification of the cross-linked (X) fractions. Error bars represent SD from three replicates. (C) BLI analysis of the interaction between a premix of 1 μM Caulobacter ParB-His6 ± 1 mM CTP or CTPγS and a 169 bp dual biotin-labeled parS DNA. CTP or CTPγS was added to purified ParB, and the mixture was immediately used for BLI experiments. All buffers used for experiments in this figure contained Mg2+.

Figure 6—figure supplement 1
Caulobacter ParB binds CTP and a non-hydrolyzable analog CTPγS but not CMP-PCP.

CTPγS (but not CMP-PCP) outcompeted radioactive CTP α-P32 for binding to ParB-parS complex, indicating that Caulobacter ParB can bind to CTPγS. Binding to radioactive CTP α-P32 was monitored by DRaCALA assay. The bulls-eye staining indicates CTP binding due to a more rapid immobilization of protein-ligand complexes compared to free ligands alone.

Figure 6—figure supplement 2
BLI analysis and gel analysis of cross-linking products of purified Caulobacter ParB (Q35C C297S).

(A) BLI analysis of the interaction between a premix of 1 μM His-tagged ParB (C97S) or (Q35C C297S) ± 1 mM CTP and a 169 bp dual biotin-labeled parS DNA. In the presence of CTP, both variants of ParB were able to spread, indicating that the engineered mutations Q35C and C297S did not impair the function of ParB in vitro. (B) Purified Caulobacter ParB-His6 (Q35C C297S) ± NTPs ± parS DNA were incubated for 15 min at room temperature before cross-linking with BMOE. A cysteine-less ParB (C297S) was used as a negative control. X indicates a cross-linked form of ParB. A solid black triangle on lane four indicates a contaminated protein from the purification of ParB-His6 (Q35C C297S). A lower panel shows the quantification of the cross-linked (X) fractions. Error bars represent SD from three replicates.

A model for Caulobacter ParB nucleation and spreading.

(A) Caulobacter ParB nucleation at parS. CTP (orange) reduces Caulobacter ParB (dark green) nucleation at parS (magenta box), presumably by inducing conformational changes that are incompatible with a site-specific parS binding (Soh et al., 2019). Only apo- or CDP-bound ParB can nucleate on parS. ParB hydrolyzes CTP at a faster rate in the presence of parS. The domain architecture of ParB is also shown: NTD: N-terminal domain, DBD: DNA-binding domain, and CTD: C-terminal domain. (B) Caulobacter ParB escapes from the nucleation site parS. Apo-ParB at parS binds CTP and slides laterally away from the nucleation site parS while still associating with DNA. (C) Caulobacter ParB sliding and spreading on DNA. CTP-bound ParBs diffuse from the nucleation site parS and can run off the free DNA end unless they are blocked by DNA-bound roadblocks such as transcriptional regulators for example TetR. CTP hydrolysis is not required for ParB to escape from the nucleation parS site but might contribute to ParB recycling. It is not yet known whether both CTP molecules on a ParB dimer are concertedly hydrolyzed/dissociated for ParB to escape from the chromosome or a heterodimer state of ParB with a single CTP bound also exists in vivo.

Tables

Key resources table
Reagent type (species)
or resource
DesignationSource or referenceIdentifiersAdditional
information
Strain, strain background (Escherichia coli)Rosetta (DE3)MerckCat# 70954Electro-competent cells
Recombinant DNA reagentSee Supplementary file 1This paperSee Supplementary file 1
Sequence-based reagentSee Supplementary file 1This paperSee Supplementary file 1
AntibodyAnti-6xHis tag antibody (HRP) (Rabbit polyclonal)AbcamCat# ab1187Western blot (1:5,000)
Commercial assay or kitEnzChek Phosphate Assay KitThermoFisherCat# E6646
Commercial assay or kitGibson Assembly Master MixNEBCat# E2611S
Commercial assay or kitGateway BP Clonase II enzyme mixThermoFisherCat# 11789020
Commercial assay or kitDip-and-Read Streptavidin (SA) biosensorsMolecular DevicesCat# 18–5019
Commercial assay or kitHisTrap High Performance columnGE HealthcareCat# GE17524801
Commercial assay or kitHiTrap Heparin High Performance columnGE HealthcareCat# GE17040601
Commercial assay or kitHiLoad 16/600 Superdex 75 pg columnGE HealthcareCat# GE28989333
Commercial assay or kitDynabeads MyOne Streptavidin C1ThermoFisherCat# 65001
Commercial assay or kitAmersham Protran supported Western blotting membranes, nitrocelluloseGE HealthcareCat# GE10600016pore size 0.45 μm, for DRaCALA assay
Peptide, recombinant proteinBamHI-HFNEBCat# R3136S20,000 units/mL
Peptide, recombinant proteinBamHINEBCat# R0136S20,000 units/mL
Peptide, recombinant proteinEcoRI-HFNEBCat# R3101S20,000 units/mL
peptide, recombinant proteinHindIII-HFNEBCat# R3104S20,000 units/mL
Peptide, recombinant proteinExonuclease VIINEBCat# M0379S10,000 units/mL
Peptide, recombinant proteinExonuclease T7NEBCat# M0263S10,000 units/mL
Chemical compound, drugBenzonase nucleaseSigma-AldrichCat# E1014
Chemical compound, drugNTPThermoFisherCat# R0481100 mM solution
Chemical compound, drugCTPγSJena BioscienceA gift from S. Gruber and
custom synthesis (purity ≥ 96%)
Chemical compound, drugCMP-PCPJena BioscienceCat# NU-254
Chemical compound, drugP32-α-CTPPerkin ElmerCat# BLU008H250UC3000 Ci/mmol, 10 mCi/ml, 250 µCi
Chemical compound, drugAnhydrotetracycline hydrochloride (ahTc)AbcamCat# ab145350Dissolved in ethanol
Chemical compound, drugBismaleimidoethane (BMOE)ThermoFisherCat# 22323Dissolved in DMSO
Software, algorithmBLItz ProMolecular DevicesCat# 50–0156Version 1.2 https://www.moleculardevices.com/
Software, algorithmRR Foundation for Statistical ComputingRRID: SCR_001905Version 3.2.4
Software, algorithmImage Studio LiteLI-COR BiosciencesRRID: SCR_013715Version 5.2
Software, algorithmExcel 2016MicrosoftRRID: SCR_016137

Additional files

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Adam SB Jalal
  2. Ngat T Tran
  3. Tung BK Le
(2020)
ParB spreading on DNA requires cytidine triphosphate in vitro
eLife 9:e53515.
https://doi.org/10.7554/eLife.53515